$11.37
-0.11-0.96%
At close: -
$11.18
-0.19-1.67%
After Hours: 6:55 PM EDT
Enfusion reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Enfusion using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-03 | $0.03 | $0.06 | -50.0 % |
Q3 | 2024-11-04 | $0.05 | $0.06 | -16.7 % |
Q2 | 2024-08-06 | $0.05 | $0.06 | -16.7 % |
Q1 | 2024-05-09 | $0.06 | $0.04 | 50.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-03 | $52.94M | $54.39M | -2.67 % |
Q3 | 2024-11-04 | $51.17M | $52.17M | -1.92 % |
Q2 | 2024-08-06 | $49.46M | $50.05M | -1.19 % |
Q1 | 2024-05-09 | $48.05M | $47.61M | 0.93 % |
Enfusion (ENFN) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
The Actual EPS was $0.03, which missed the estimate of $0.06.
The Actual Revenue was $52.9M, which missed the estimate of $54.4M.
Browse earnings estimates, EPS, and revenue on all stocks.